Instem, a leading provider of IT
solutions to the global early development healthcare market, is
pleased to announce the release of version 9 of its world-leading,
preclinical software suite, Provantis®.

Version 9 was developed in close collaboration with Instem clients as
part of its overarching Customer Involvement Program (CIP). This
included a comprehensive Beta Test Program involving valued clients such
as Bristol-Myers Squibb, GlaxoSmithKline, MPI Research, Roche, Sanofi
and Sequani, as well as Webcasts, product demonstrations, Special
Interest Group meetings and dedicated sessions at the Instem
International Conferences.

The eagerly anticipated release contains major enhancements to the Clinical
Pathology module, delivering a more flexible, scalable,
cost-effective and highly efficient sample-driven solution. Provantis 9
offers Clinical Pathology professionals a complete, end-to-end,
integrated solution, which delivers additional efficiency gains at each
step of the way; from the taking of the sample, through the Clinical
Pathology laboratory, to the presentation of results.

New Interface from Instem’s formulation system, Dispense,
to the Quantos™ Dosing System

In addition to new capabilities at the application level, Provantis
version 9 also incorporates a major technology upgrade, ensuring that
clients are able to take advantage of the latest investments in 64-bit
technology and the Oracle and Microsoft platforms.

Mike Harwood, Instem’s Senior Vice President, comments, “Client feedback
throughout this development project has been extremely positive and has
helped to ensure that version 9 is a robust, high quality,
fit-for-purpose application for the Tox/Path market. The features
included in version 9 are in high demand; numerous clients have
committed to upgrading with several more poised to sign shortly.”

Provantis 9 is a comprehensive release that will be supported by a
global awareness program aimed at demonstrating the specific benefits it
brings in terms of increased productivity, ease of use and efficiency
gains in the short and longer terms. This will begin with a series of
launch Webcasts taking place during the week of Monday, February 11th.

Instem is a leading supplier of IT applications to the early development
healthcare market delivering compelling
solutions for data collection, management and analysis across the
R&D continuum. Instem applications are in use by customers worldwide,
meeting the rapidlyexpanding needs of life science and
healthcare organizations for data-driven decision making leading to
safer, more effective products.

Thanks to the plethora of communication and messaging apps available to the average user, unified communications (UC) is becoming more important than ever before. UC is a set of products and services designed to give employees a uniform communications experience, integrating different ...

Cloud providers like AWS have proven to be a viable option for running mainframe application workloads. The most effective method to exploit the value of Unisys mainframe applications and data is a transformative migration to modern systems frameworks in AWS, reusing as much of the ori...

Having a well-rounded brand strategy helps you identify the marketing channels you must focus on, and defines every aspect of how your business is viewed by your customers.
Marketing and advertising is an integral component of every business. The US Small Business Administration reco...

When you work with React app, it normally needs some data from the server to store it for immediate use (e.g., show it on the page). If the app works with some complex relational database the work than may be a bit challenging. In this article I am going to describe the issues with org...

Technology integration is complex and an evergreen business challenge for IT teams. Enterprises setup manual & point to point connections to exchange data from business partners. However, data disruptions emerge when the business IT systems expand and prevents organizations from sharin...